Warberg Asset Management’s Clearmind Medicine CMND Stock Holding History
Bought
Maintained
Sold
Other funds holding CMND
Warberg Asset Management's CMND Position: Q4 2023 in Review
Warberg Asset Management sold out of Clearmind Medicine (CMND) in Q4 2023, closing a stake of 18 shares — an estimated $35.2K sold.
Warberg Asset Management first reported a position in CMND in Q3 2023 and held it in 1 quarter. The position peaked at $35.2K in Q3 2023. 1 fund tracked by Wall St. Rank holds CMND as of Q4 2023.
- Warberg Asset Management reported no remaining Clearmind Medicine position as of Q4 2023 after selling out during the quarter.
- Warberg Asset Management sold 18 Clearmind Medicine shares in Q4 2023, an estimated $35.2K.
- Warberg Asset Management first reported a position in Clearmind Medicine in Q3 2023 and held it in 1 quarter.
- Warberg Asset Management's Clearmind Medicine position peaked at $35.2K in Q3 2023.
- 1 fund tracked by Wall St. Rank held Clearmind Medicine as of Q4 2023.
Based on Warberg Asset Management's 13F filing for Q4 2023, filed 7 Feb 2024.